Lensar (LNSR) Cash & Equivalents (2019 - 2026)
Lensar's (LNSR) quarterly Cash & Equivalents came in at $10.1 million in Q1 2026, down 48.35% year-on-year from $19.5 million in Q1 2025, and down 21.45% on a QoQ basis from $12.9 million in Q4 2025.
Lensar (LNSR) Cash & Equivalents (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Cash & Equivalents data on file, last reported at $10.1 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 48.35% year-over-year to $10.1 million in Q1 2026; TTM through Mar 2026 was $10.1 million, a 48.35% decrease from a year earlier, with the FY2025 full-year figure at $12.9 million, changed 0.24% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $10.1 million, down from $12.9 million in the prior quarter.
- Over the last five years, Cash & Equivalents for LNSR reached as high as $29.0 million in Q1 2022 and fell as low as $7.2 million in Q2 2025.
- Historically, Cash & Equivalents has averaged $16.3 million across 5 years, with a median of $13.8 million in 2022.
- Across the five-year window, Cash & Equivalents soared 40.53% in 2023 and sank 58.1% in 2024, its largest moves.
- Year by year, Cash & Equivalents stood at $14.7 million in 2022, then jumped by 40.53% to $20.6 million in 2023, then plunged by 37.82% to $12.8 million in 2024, then increased by 0.24% to $12.9 million in 2025, then dropped by 21.45% to $10.1 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $10.1 million in Q1 2026, $12.9 million in Q4 2025, and $12.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 557.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.03 Bn |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn | 10.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.10 Mn |
| Dec 31, 2025 | 12.85 Mn |
| Sep 30, 2025 | 12.76 Mn |
| Jun 30, 2025 | 7.15 Mn |
| Mar 31, 2025 | 19.55 Mn |
| Dec 31, 2024 | 12.82 Mn |
| Sep 30, 2024 | 10.44 Mn |
| Jun 30, 2024 | 12.48 Mn |
| Mar 31, 2024 | 15.30 Mn |
| Dec 31, 2023 | 20.62 Mn |
| Sep 30, 2023 | 24.92 Mn |
| Jun 30, 2023 | 25.47 Mn |
| Dec 31, 2022 | 14.67 Mn |
| Mar 31, 2022 | 28.98 Mn |
| Dec 31, 2021 | 31.64 Mn |
| Sep 30, 2021 | 32.34 Mn |
| Jun 30, 2021 | 34.55 Mn |
| Mar 31, 2021 | 35.87 Mn |
| Dec 31, 2020 | 40.60 Mn |
| Sep 30, 2020 | 42.70 Mn |